US Patent 6890518 Compositions of chemically modified insulin
Patent 6890518 was granted and assigned to Nektar (pulminary therapeutics business unit) on May, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 20 Oct, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+316 characters)
Article
Patent abstract
The present invention provides active, hydrophilic polymer-modified derivatives of insulin. The insulin derivatives of the invention are, in one aspect, suitable for delivery to the lung and exhibit pharmakokinetic and/or pharmacodynamic properties that are significantly improved over native insulin.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Blaine Bueche0
Chester Leach0
J. Milton Harris0
John S. Patton0
Kimberly Perkins0
Mei-Chang Kuo0
Date of Patent
May 10, 2005
0Patent Application Number
104051900
Date Filed
April 1, 2003
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6890518 Compositions of chemically modified insulin
Find more entities like US Patent 6890518 Compositions of chemically modified insulin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
